It is not yet known whether the detection or elevation of BCL2A1-gene-related markers (i.e., cell-free fetal [cff] DNA and cff-RNA) in maternal plasma can be used to predict either the presence or the stage progression of acute HCA in the EPM. The gene discussed is HCFC1; the disease is hepatocellular adenoma.